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ABSTRACT 
Objective: Localization of ranitidine hydrochloride (RH) into the upper part of the intestinal tract is beneficial for better drug bioavailability. 
Present work described the method of preparation of novel plant polysaccharide based floating microspheres for delivery of the drug into the 
stomach. 
Methods: Polysaccharide was extracted from the seeds of plant Tamarindus indica (TI). Extracted polysaccharide was evaluated for some 
physicochemical parameters. Floating-mucoadhesive microspheres were prepared by using extracted polysaccharide as mucoadhesive excipients 
while eudragit as a release controlling polymers by using emulsion crosslinking method. Chemical crosslinking was done by using epichlorohydrin. 
Prepared microspheres were evaluated for their drug-polymer compatibility study by using fourier transform infrared spectroscopy (FT-IR). 
Further characterization such as size, surface properties, swelling index, percentage encapsulation, in vitro buoyancy and drug release was 
performed. 
Results: FT-IR study confirms the chemical crosslinking of extracted polysaccharide and also drug stability during processing of microspheres. The 
size of microspheres was in the range of 5.38 to 7.84 µm. SEM images revealed that all batches were of spherical in size and smooth surface. The 
swelling index showed better swelling in the range of 158-257 percentages. Encapsulation efficiency was found to be decreased by decreasing the 
concentration of polysaccharide. In vitro buoyancy study possesses that formulation F1 showed better floating ability as compared to the others. 
Finally, in vitro drug release study revealed that prepared microspheres were able to release the 100% drug within 8-12 h, indicating sustain 
release behavior.  
Conclusion: Present study concludes that polysaccharide of TI may be used as excipients for the preparation of floating-mucoadhesive 
microspheres. 
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RH is a commonly used antacid as H2
The floating system is used for localized drug release into the 
specific region of the gastrointestinal tract (GIT). This system can be 
effervescent or non-effervescent depends on ingredients used in the 
delivery system. The most commonly used excipients in non-
effervescent floating drug delivery system are either swellable or gel 
forming hydrocolloids and polysaccharide. These systems are also 
known as plug type system due to the tendency to remain lodged 
near the pyrrolic sphincter [3]. Nowadays, a large number of plant 
polysaccharide has been investigated for their potential role in the 
floating drug delivery system. These polymers have a tendency to 
swell on gastric media and float, therefore, increasing the residential 
time of formulation into the upper part of GIT. Additionally, this 
plant polysaccharide has some advantages such as biodegradable, 
biocompatible, low cost and relatively free availability [4].  
 receptor antagonist which 
shows maximum absorption at the initial part of small intestine. 
Moreover, colonic metabolism is also responsible for poor oral drug 
bioavailability [1]. Effective treatment can be achieved by 
administration of 200 mg of RH, three times a day, which leads to a 
patient in compliance. In order to improve therapeutic action and 
patient compliance, it is required to design a formulation which can 
increase the retention of the drug into the upper part of along with 
sustain release action up to 12 h [2].  
With the same context, in the present work drug loaded floating 
mucoadhesive microspheres were developed to improve the 
residential time of RH into upper GIT. A novel plant polysaccharide 
was investigated for their application in the mucoadhesive delivery 
system. The polysaccharide was isolated from the seeds of TI. The 
polysaccharide of TI is nonionic, neutral, branched structure consist 
of cellulose like backbone which carries xylose and galactoxylose 
subunits. Polysaccharide has been investigated for many 
applications such as gelling agent, tablet binder, stabilizer and 
thickening agent [5, 6]. So far, the polysaccharide is not evaluated in 
the floating drug delivery system. Aim of present work was to 
investigate the role of novel TI polysaccharide in development of 
floating mucoadhesive microspheres for localized drug delivery of 
RH specifically into upper parts of GIT.  
MATERIALS AND METHODS 
RH was obtained as generous gift sample from Hetero labs, 
Hyderabad, India. Seeds of TI were purchased from local market of 
Kanpur (UP). All other materials such as Eudragit, castor oil, 
epicholorhydrin, and sodium bicarbonate were of analytical grade 
and were procured from commercial sources. 
Polysaccharide extraction  
TI polysaccharide was extracted as per reported methods in various 
publications [7]. The seed were process by separating the brown 
peels from the kernel seed with the blender and plastic sieve were 
used to separate the seed. The seed were powdered and boiled with 
distilled water. Mucilaginous juice was separated by filtration 
through muslin cloth under vacuum and precipitated by ethanol. 
Precipitate was dried at 50 °C for 2 d. Further, the extracted dry 
polysaccharide was characterised in terms of purity and viscosity. 
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The purity of the polysaccharide was evaluated by testing the 
presence of carbohydrate, by performing the molisch’s, ruthenium, 
and iodine test. The viscosity of 2% w/v aqueous solution of 
polysaccharide was determined by using rheometer (Brookfield R/S 
plus, Massachusetts, USA) of cone and plate geometry equipped with 
C-25 din measuring spindle at a shear rate 10 (s-1
Microspheres were prepared by using cross-linking emulsification 
method described by Nitin et al. [8]. The accurately weighed amount of 
RH was dissolved into distilled water to make 20 mg/ml drug solution. 
Varied amount of extracted polysaccharide and eudragit were dispersed 
into drug solution to make 2% w/v dispersion of both excipients (TI 
polysaccharide and eudragit) (table 1). Sodium bicarbonate (0.1:1with 
TI polysaccharide) was dissolved into aqueous phase.  
) for 100 sec at 
34±0.5 °C temperature. 
Preparation of microspheres 
Aqueous phase was allowed for complete hydration till 4 h under 
stirring using a magnetic stirrer. Hydrated aqueous phase was 
emulsified in castor oil (1:10 aqueous to oil phase ratio) using span 80 
(1.0% v/v) at high-speed homogenizer (2000 rpm, Yamato, LT400, 
Tokyo, Japan). Sulphuric acid (0.2 ml) and epichlorohydrin (as chemical 
crosslinker, 4.0% v/v) were added. And stirring was continued till 18 h 
at 45 °C. Finally, microspheres were collected by centrifugation followed 
by its washing using isopropyl alcohol and dried at 60 °C for 5 h. 
  















F1 100 - 7.84±0.34 257±26 87.35±12.43 88.47±17.44 
F2 75 25 3.51±0.11 212±31 81.72±18.29 86.57±11.29 
F3 50 50 6.48±0.36 187±13 78.05±9.55 85.49±9.34 
F4 25 75 5.38±0.52 158±39 76.40±5.49 82.57±10.29 
*Percentage of TI polysaccharide and eudragit was for total content of both excipients to make 2% w/v dispersion into aqueous phase  
 
Characterization of microspheres  
FT-IR study 
The FT-IR spectra of RH, extracted polysaccharide and prepared 
microspheres were recorded to determine any possible chemical 
changes of drug during microspheres preparation. Dried KBr was used 
as diluent and samples were scanned over the range of 4000 to 400 
cm-1
Morphology 
 by using FT-IR spectrophotometer (Shimadzu 84005, Japan). 
Surface morphology of prepared microspheres was studied using 
scanning electron microscopy (SEM). The samples were sprinkled 
on an aluminium stub by using double sided adhesive tape and then 
gold sputter coated at 50mA under an argon atmosphere (POLARON 
model SC-76430). The thickness of the coating was 200 Å. Images 
were captured in the magnification range of 3000 X by using 
electron microscope (LEO-430, UK). 
Particle size analysis 
The particle size determination was done by using phase contrast 
microscope (Radical Instruments, Ambala Cant, India). Prepared 
microspheres were suspended into light paraffin oil. Few drops (2-
3) of this suspension were shifted over the glass slide and covered 
with a coverslip. The diameter of approximate 300 microspheres 
was measured and the average diameter was calculated.  
Swelling ratio 
Swelling property of prepared floating microspheres was studied as 
per the method described by Rana et al. [9]. Briefly, known weight 
(25 mg) of microspheres were soaked at 37±0.5 °C in phosphate 
buffer (pH 1.2) solution. After a certain time, period microspheres 
were and excess media was removed by blotting with suitable 
media. Swollen microspheres were weighed by using electronic 
balance (Shimadzu AUX220, Japan). The degree of swelling (α) was 
calculated by using equation 1. 
α = Wg−Wo
Wo
 x 100 (1) 
Where Wo is the initial weight of microspheres and Wg 
In vitro buoyancy study 
is the weight 
after swelling. 
In order to explore the floating ability of prepared microspheres in 
vitro buoyancy study was performed according to the method 
describe by Dey et al. [10]. The study was carried out in 0.1 N HCl 
containing 0.02% v/v tween 80. Prepared microspheres were 
dispersed into the 900 ml of media at 37±0.5 °C. Paddle was rotated 
at 100 rotations per minute. Each fraction of microspheres floated 
on the surface and those settled down were recorded at a 
predetermined time interval. Settled microspheres were collected, 
dried and weighed.  
Encapsulation efficiency 
These parameters were estimated by dispersing accurately weighed 
quantity of crushed powder of prepared microspheres (25 mg) into 25 
ml distilled water. The dispersion was kept overnight with under 
continuous shaking for complete release of RH from microspheres. 
Debris of microspheres was removed by filtration and centrifugation. 
The absorbance of the filtrate was measured after suitable dilution using 
UV-visible spectrophotometer (Shimadzu 1700, Japan) at 313 nm. 
Experiments were carried out in triplicate and the encapsulation 
efficiency and drug content were calculated by using equations 2. 
Encapsulation efficiency (%)  =  actual amount of drug
theoretical amount of drug
×100 (2) 
In vitro dissolution studies 
For determination of in vitro dissolution study, accurately weighed the 
quantity of prepared microspheres (equivalent to 300 mg of RH) was 
transferred in the beaker having 900 ml phosphate buffer (pH 1.2), 
temperature 37±1 °C; staring rate 100 rpm. At predetermined time 
intervals, aliquots of 1 ml were withdrawn, replaced by equal volume of 
fresh media and centrifuged at 4000 g for 15 min. Finally, the 
supernatant was estimated for drug content by using UV-visible 
spectrophotometer at 313 nm. Further, the exact mechanism of drug 
release from the microspheres was calculated by fitting release data 
different release kinetic models such as zero-order, first-order, Higuchi’s 
and Korsmeyer-Peppas equations. Data of release kinetics such as of 
kinetic rate constant (k), correlation coefficient (r2
RESULTS AND DISCUSSION 
) and release exponent 
(n) were calculated for the determination of best fit model [11]. 
The polysaccharide of TI was extracted by using precipitation method 
with percentage yield of 13.59 %w/w. The brownish red dry 
polysaccharide was characterized for their purity and viscosity. As a 
result, it was found that extracted polysaccharide was of carbohydrate 
in nature. Presence of mucilage and absence of any other ingredients 
indicates the high level of purity of extracted polysaccharide. Similarly, 
2.0% w/v aqueous solution showed 304±21 mPas viscosity at shear 
rate 10 (s-1) and 37±0.5 °C temperature. Junginger et al., (2007) 
suggested a relation between viscosity and mucoadhesion of polymers 
[12]. According to this relation a mucoadhesion property of polymer is 
only triggered by its swelling behavior. For effective mucoadhesion, 
polymer need to swell first, followed by interpenetration into 
biological tissue. Therefore, high value of viscosity indicates that the 
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extracted polysaccharides may be considered as excipients for 
mucoadhesive drug delivery. Emulsification cross-linking method was 
found to be a suitable method for the preparation of RH loaded TI 
based microspheres. The percentage yield of prepared microspheres 
was in the range of 78-81% w/w. Epichlorohydrin was used as a 
chemical cross linking agent, which has been used for cross-linking of 
various carbohydrates. Chemically, it is an organochlorine compound 
(an organic compound containing at least one covalent bonded atom 
of chlorine) and an epoxide (cyclic ether with three ring atom).  
FT-IR study 
The FT-IR spectra of RH, extracted polysaccharide and prepared 
microspheres are shown in fig. 1. The characteristic peaks of RB and 
extracted polysaccharide were studied by using the previously 
reported literature [13]. Obtained FT-IR spectra of RH were compared 
with spectra of microspheres. The study indicates that all 
characteristic peaks of RH were present in the spectra of 
microspheres, which revealed that the drug was unchanged during the 
preparation of microspheres.  
However, some new peaks were observed in the spectra of 
microspheres at frequencies 1164 and 867 cm-1
  
, which may be due to 
the formation of mono and diether linkage as the result of chemical 
cross-linking between extracted polysaccharide and epichlorohydrin. 
The absence of any new peak in the FT-IR spectra of microspheres also 
confirmed the absence of any by-product through epichlorohydrin 
mediated polysaccharide cross linking. 
 
Fig. 1: FTIR spectra of drug RH (a), extracted plant polysaccharide (b) and prepared floating-mucoadhesive microspheres 
 
Surface morphology 
Surface characteristics of different batches of prepared TI 
polysaccharide based microspheres were examined by using 
scanning electron microscopy (SEM). Fig. 2 indicates the SEM images 
of prepared microspheres of all batches. Visual examination of the 
SEM pictures indicated that all batches of microspheres were of 
spherical shape with varied surface roughness. Present investigation 
indicates that there were no any significant effects of variables on 
surface morphology of microspheres. 
Particle size 
Particle sizes of all batches of drug loaded TI polysaccharide based 
microspheres were evaluated by using simple microscopic methods. 
Particle size of all batches of microspheres was in the range of 5.38-
7.84 µm (table 1). The present study indicated that there was not 
any remarkable effect of concentration of excipients on the particle 
size of prepared microspheres. 
Swelling ratio 
Swelling behavior of microspheres defines the extent of 
mucoadhesion and drug release pattern through it. Therefore, 
evaluation of this study becomes essential while preparing any 
mucoadhesive formulations. The effect of varied concentration of TI 
polysaccharide and eudragit on the swelling index of the 
microspheres was evaluated (fig. 3). Fig. indicates that swelling 
index was gradually decreased by decreasing the concentration of TI 
Sahu et al. 
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polysaccharide. Batch F1 showed highest swelling, while batch F4 
showed minimum swelling. This might be due to insufficient 
polysaccharide content to swell. Highest swelling index F1 may be 
due to highest polysaccharide concentration.  
Since, polysaccharides are consist of large numbers of polar 
compound which leads to water absorption and holding 




Fig. 2: SEM images of all batches of microspheres prepared by using extracted TI polysaccharide 
 
 
Fig. 3: Percentage swelling index of TI polysaccharide based 
floating-mucoadhesive microspheres measurement was done 
in triplicates (n=3, mean±SD) 
 
In vitro buoyancy study 
The purpose of preparing floating microspheres was to extend the 
gastric residence time of the drug. Floating ability of prepared 
microspheres was determined by using in vitro buoyancy study in 
0.1 N HCl containing 0.02% v/v tween 80. Tween 80 was added to 
counteract the downward pulling at the liquid surface by lowering 
surface tension. The prepared microspheres floated immediately on 
the medium, and the floating lag time (min.) was zero for all the 
formulations. The absence of floating lag time is ideal to prevent 
dosage form from the transition to the intestine which could be due 
to low density of prepared microspheres [14]. Obtained data of in 
vitro buoyancy study are given in table 1.  
Formulation F1 possesses best floating ability (87.35% w/w) while 
it gradually decreased by replacing the concentration of TI 
polysaccharide by eudragit. Floating ability of prepared 
microspheres may be co-related as per the swelling characteristic of 
microspheres. Due to the highest concentration of TI polysaccharide 
in formulation F1, these particles swell to its highest extent and 
become floatable. Since eudragit are not swellable therefore by 
increasing the concentration of eudragit, microspheres started to 
sediments.  
Encapsulation efficiency 
Data of encapsulation efficiency of prepared microspheres are 
shown in table 1. Values of percentage encapsulation efficiency 
were increased by increasing the TI polysaccharide concentration 
in respect to the concentration of eudragit. The reason may be, 
increase in polysaccharide concentration leads to increase in the 
viscosity of aqueous phase and highly viscous phase shows high 
drug retention capacity by preventing the migration of drug from 
droplets to surrounding media which result to more encapsulation 
efficiency [12]. 
In vitro dissolution studies 
The in vitro releases of RH from all batches prepared by using a 
mucoadhesive TI polysaccharide and a rate controlling polymer 
(eudragit) are illustrated in fig. 4. All the formulations showed drug 
released pattern till 12 h course of study. Initially, at 30 min 
30.73%w/w, 24.16%w/w, 21.90%w/w and 17.75%w/w drug was 
released from the formulations F1, F2, F3 and F4 respectively. The 
rate of drug release was found gradually decreased by increasing the 
concentration of eudragit concentration into the prepared 
microspheres. Increased concentration of eudragit into 
microspheres make an impermeable three-dimensional network 
through which drug migration become difficult and as a result 
suppress the drug release. Since eudragit are insoluble at acidic pH, 
therefore at highest concentration (F4) drug release was found to be 
decreased. Moreover, all prepared TI polysaccharide based 
formulations were found to be release 100%w/w of RH from 8 to 12 
Sahu et al. 
Int J App Pharm, Vol 9, Issue 3, 2017, 15-19 
 
19 
h into acidic media. Rationally, the prepared microspheres can be 
delivered the drug into the upper part of GIT up to 12 h.  
The exact mechanism of drug release from prepared microspheres 
was calculated by fitting the release data into several models. The 
criterion of selection of best model was based on the goodness of fit. 
It was observed that drug release from microspheres followed 
Higuchi square root kinetics for the formulations F2, F3 and F4. 
While the formulation F1 (solely containing TI and not containing 
Eudragit) followed korsemeyer peppas kinetics having the value of n 
was 0.352. This shows that the release drug release kinetics of the TI 
microspheres (F1) was a fickian. However, the formulations F2, F3 
and F4 followed diffusional kinetics according to Higuchi’s equation, 
all the plots were linear with correlation coefficient values (r2) in 
the range of 0.8914–0.9452 (table 2), indicating diffusion controlled 
drug release. Finally, in order to know the exact mechanism of drug 
diffusion through prepared microspheres, the release data was fit 
into Korsmeyer–Peppas equation. All the plots were found to be 
linear with r2 values in the range of 0.9764–0.9936 (table 2). The 
release exponent (n) values for all batches were found to be more 
than 0.45, indicating Fickian release.  
 
Fig. 4: Percentage release of RH from TI polysaccharide based 
floating-mucoadhesive microspheres (n=3, mean±SD)
 
Table 2: Values of kinetic rate constant (k), correlation coefficient (R2
Formulations 
) and release exponent (n) from different batches of prepared 
microspheres 
Zero-order First-order Higuchi Korsmeyer-Peppas 
K R k 2 R k 2 R K 2 R n 2 
F1 0.107 0.751 -0.107 0.751 3.565 0.928 10.881 0.955 0.352 
F2 0.116 0.819 -0.116 0.819 3.762 0.963 2.832 0.961 0.643 
F3 0.115 0.843 -0.115 0.843 3.699 0.973 2.6143 0.923 0.648 
F4 0.115 0.864 -0.115 0.864 3.687 0.981 2.1149 0.940 0.659 
 
CONCLUSION 
The present study concludes that the extracted plant polysaccharide 
of TI can be considered as excipients for the development of 
floating-mucoadhesive drug delivery. Extracted polysaccharide 
possesses an optimized value of viscosity and extraction procedure 
was found suitable with optimum yield. Prepared microspheres 
found suitable in buoyancy study with high encapsulation efficiency. 
Finally, in vitro release study indicates that microspheres were able 
to release the RH up to 12 h into acidic media. Further investigations 
such as stability studies, scale-up studies and in vivo 
pharmacokinetic studies are needed for the establishment of 
Tamarindus indica polysaccharide as pharmaceutical excipients for 
microspheres drug delivery systems.  
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